The LDI is among Canada’s leading health research institutes. Through their fundamental and clinical investigations, our scientists and clinicians make significant discoveries, lead important provincial and national research programs, and train emerging scientists who, themselves, are recognized for the excellence of their work, contributing to the health and well-being of patients in Quebec, Canada, and around the world.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
Discover our 200+ regular and associated investigators and their research, as well as the many services we provide across the spectrum of the research process.
We offer the 250+ graduate and postdoctoral students who come to the LDI each year an open, collaborative, and multidisciplinary training environment that fosters excellence.
The close collaboration between researchers, clinicians, and patients is at the basis of the most successful research programs and clinical trials at the LDI.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
Congratulations to @LDI_ILD trainees Mehdi Haghi and Nicolas Terzopoulos and all other recipients of the 2026 D2R Scholar Awards.
We are very thankful to D2R for their support. Congratulations to Johanna Toth on the 2026 D2R Scholar Award: 'Lipid Nanoparticle-Mediated mRNA Therapy for Sickle Cell Disease Through Targeted Delivery to Erythroid Precursors'.
🎉 Congratulations to the recipients of the 2026 D2R Scholar Awards!
This year, D2R is supporting 30 outstanding Master's and Doctoral students conducting #RNAResearch at @McGillU, @uOttawa, @UBC, @USherbrooke.
🔗https://www.mcgill.ca/dna-to-rna/channels/news/d2r-continues-invest-canadas-next-generation-rna-research-leaders-374291
📢
Master’s students!
The Research Portal is now accepting applications for the Canada Graduate Research Scholarship - Master’s (CGRS M) program.
▶️ https://tinyurl.com/2s43e5fp
Application deadline:
🗓️ December 1, 2026 before 8 pm (ET)
#NSERCSupport
#NSERC_CGRSM
An updated systematic review reinforces the effectiveness of #GLP1 based therapies for weight loss among adults with overweight or obesity who do not have diabetes. The review found that #tirzepatide produced the greatest weight loss among currently available treatments, while